NCT01690949View on ClinicalTrials.gov

Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

PUR118

inhaled PUR118, BID

Trial Locations (1)

30625

Fraunhofer Institut fur Toxicologie und Experimentelle Medicine (ITEM), Hanover

All Listed Sponsors
lead

Pulmatrix Inc.

INDUSTRY

NCT01690949 - Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers | Biotech Hunter | Biotech Hunter